BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37670247)

  • 1. Regulatory T cell frequency in peripheral blood of women with advanced cervical Cancer including women living with HIV.
    Chetty-Sebastian D; Assounga AG
    BMC Cancer; 2023 Sep; 23(1):830. PubMed ID: 37670247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus and human immunodeficiency virus infections: relation with cervical dysplasia-neoplasia in African women.
    La Ruche G; You B; Mensah-Ado I; Bergeron C; Montcho C; Ramon R; Touré-Coulibaly K; Welffens-Ekra C; Dabis F; Orth G
    Int J Cancer; 1998 May; 76(4):480-6. PubMed ID: 9590121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of CD4+ regulatory T cells, CD8+ T cells, and human papilloma virus infection in Egyptian Women with breast cancer.
    Tawfeik AM; Mora A; Osman A; Moneer MM; El-Sheikh N; Elrefaei M
    Int J Immunopathol Pharmacol; 2020; 34():2058738420966822. PubMed ID: 33103515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depletion of Human Papilloma Virus E6- and E7-Oncoprotein-Specific T-Cell Responses in Women Living With HIV.
    Mbuya W; Held K; Mcharo RD; Haule A; Mhizde J; Mnkai J; Mahenge A; Mwakatima M; Sembo M; Mwalongo W; Agrea P; Hoelscher M; Maboko L; Saathoff E; Geisenberger O; Rwegoshora F; Torres L; Koup RA; Kroidl A; Chachage M; Geldmacher C
    Front Immunol; 2021; 12():742861. PubMed ID: 34759925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Prevalence of Cervical High-Grade Lesions and High-Risk Human Papillomavirus Infections in Women Living with HIV: A Case for Prioritizing Cervical Screening in This Vulnerable Group.
    Gupta R; Hussain S; Hariprasad R; Dhanasekaran K; Verma S; Agarwal V; Sandeep ; Parveen S; Kaur A; Verma CP; Amita ; Dwivedi R; Singh S; Gupta S
    Acta Cytol; 2022; 66(6):496-506. PubMed ID: 35760059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXP3+Helios+ Regulatory T Cells, Immune Activation, and Advancing Disease in HIV-Infected Children.
    Khaitan A; Kravietz A; Mwamzuka M; Marshed F; Ilmet T; Said S; Ahmed A; Borkowsky W; Unutmaz D
    J Acquir Immune Defic Syndr; 2016 Aug; 72(5):474-84. PubMed ID: 27003495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4(+)CD25hi regulatory T-cell frequency correlates with persistence of human papillomavirus type 16 and T helper cell responses in patients with cervical intraepithelial neoplasia.
    Molling JW; de Gruijl TD; Glim J; Moreno M; Rozendaal L; Meijer CJ; van den Eertwegh AJ; Scheper RJ; von Blomberg ME; Bontkes HJ
    Int J Cancer; 2007 Oct; 121(8):1749-55. PubMed ID: 17582606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of high-risk human papillomavirus infections and associated cervical dysplasia in HIV-positive pregnant women in Germany: a prospective cross-sectional two-centre study.
    Metz CK; Skof AS; Sehouli J; Siedentopf JP; Gebert P; Weiss F; Alba Alejandre I; Heinrich-Rohr M; Weizsaecker K; Henrich W; Kaufmann AM; Rohr I
    Arch Gynecol Obstet; 2023 Jul; 308(1):207-218. PubMed ID: 36576558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4(+)CD25(High) Treg cells in HIV/HTLV co-infected patients with neuropathy: high expression of Alpha4 integrin and lower expression of Foxp3 transcription factor.
    Matavele Chissumba R; Silva-Barbosa SD; Augusto Â; Maueia C; Mabunda N; Gudo ES; Bhatt N; Jani I; Savino W
    BMC Immunol; 2015 Sep; 16():52. PubMed ID: 26329520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of a CD4+CD25+ Foxp3+T cells subset in Egyptian Colorectal Cancer Patients.
    Elsheshtawy NM; Saad M; El-Ghamrini YM; Ziada KW
    Egypt J Immunol; 2021 Jul; 28(3):145-156. PubMed ID: 34453786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease.
    Schulze Zur Wiesch J; Thomssen A; Hartjen P; Tóth I; Lehmann C; Meyer-Olson D; Colberg K; Frerk S; Babikir D; Schmiedel S; Degen O; Mauss S; Rockstroh J; Staszewski S; Khaykin P; Strasak A; Lohse AW; Fätkenheuer G; Hauber J; van Lunzen J
    J Virol; 2011 Feb; 85(3):1287-97. PubMed ID: 21047964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus infection and associated factors for cervical intraepithelial neoplasia in women living with HIV in China: a cross-sectional study.
    Wang Q; Ma X; Zhang X; Ong JJ; Jing J; Zhang L; Wang LH
    Sex Transm Infect; 2019 Mar; 95(2):140-144. PubMed ID: 30337414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-risk papillomavirus infection among women living with human Immunodeficiency virus: Brazilian multicentric study.
    Miranda AE; Silveira MF; Travassos AG; Tenório T; Val ICC; Lannoy L; Mattos Junior HS; Carvalho NS
    J Med Virol; 2017 Dec; 89(12):2217-2223. PubMed ID: 28771777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced frequency and functional defects of CD4
    Luo L; Zeng X; Huang Z; Luo S; Qin L; Li S
    Reprod Biol Endocrinol; 2020 Jun; 18(1):62. PubMed ID: 32522204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, east Africa.
    ter Meulen J; Eberhardt HC; Luande J; Mgaya HN; Chang-Claude J; Mtiro H; Mhina M; Kashaija P; Ockert S; Yu X
    Int J Cancer; 1992 Jun; 51(4):515-21. PubMed ID: 1318265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low expressions of PD-L1 and CTLA-4 by induced CD4
    Zhao L; Zhou X; Zhou X; Wang H; Gu L; Ke Y; Zhang M; Ji X; Yang X
    Cytokine; 2020 Sep; 133():155119. PubMed ID: 32535334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained viral suppression and higher CD4+ T-cell count reduces the risk of persistent cervical high-risk human papillomavirus infection in HIV-positive women.
    Konopnicki D; Manigart Y; Gilles C; Barlow P; de Marchin J; Feoli F; Larsimont D; Delforge M; De Wit S; Clumeck N
    J Infect Dis; 2013 Jun; 207(11):1723-9. PubMed ID: 23463709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling cervical cancer elimination using single-visit screening and treatment strategies in the context of high HIV prevalence: estimates for KwaZulu-Natal, South Africa.
    Rao DW; Bayer CJ; Liu G; Chikandiwa A; Sharma M; Hathaway CL; Tan N; Mugo N; Barnabas RV
    J Int AIDS Soc; 2022 Oct; 25(10):e26021. PubMed ID: 36225139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A modified flow cytometry method for objective estimation of human CD4
    Petsiou A; Paschou SA; Vartholomatos G; Chatzigianni K; Kolaitis N; Giotaki E; Bondinas GP; Moustakas AK; Karamoutsios A; Zervou E; Tigas S; Tsatsoulis A; Papadopoulos GK
    Cytometry B Clin Cytom; 2020 May; 98(3):259-269. PubMed ID: 31571372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory T cells in a spectrum of HPV-induced cervical lesions: cervicitis, cervical intraepithelial neoplasia and squamous cell carcinoma.
    Adurthi S; Krishna S; Mukherjee G; Bafna UD; Devi U; Jayshree RS
    Am J Reprod Immunol; 2008 Jul; 60(1):55-65. PubMed ID: 18593438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.